Abstract: Several 2-[2-{(4-substitutedbenzylidene)-phenyl}vinyl]-4-oxo-3,4-dihydroquinazolone-6-sulfonicacid 4(a-l) and 2-[2-{4-(3-chloro-4-substituedphenylazetidin-2-one)-phenyl}vinyl]-4-oxo-3,4-dihydroqui-nazolone-6-sulfonic acid 5(a-l) were synthesized by using conventional techniques and were screened for antibacterial and antifungal activity. The compounds showed good to moderate antimicrobial activity and were characterized on the basis of spectral analysis. .
Introduction
Quinazolone derivatives attract a widespread interest due to the diverse biological activities 1 associated with them. They are pharmaceutically important as antituberculars 2 , antibacterial 3 , antiparkinsons 4 and they also show blood platelet anti-aggregating activity. 5 Formation of 2-alkyl-4 (3H) quinazolinones by condensation of anthranilic acid or substituted anthranilic acid and amides is designated as the Niementowski reaction. 6 Schiff base posses diversified biological applications [7] [8] . Azetidinone also possess a variety of pharmacological properties viz CNS depressant 9 , anticonvulsant 10 , amebicidal 11 , fungicidal and antibacterial 12 . In a view of these observations we thought if of interest to undertake the synthesis and bioassay of compounds having quinazolone nucleus along with Schiff Base and Azetidinone moieties in a single molecular framework as possible antibacterial and antifungal agents. The present paper reports the synthesis of some new Schiff Base and Azetidinone in quinazolone by niementowski reaction.
Condensation of 5-Sulpho anthranilic acid with Acetyl Chloride in presence of pyridine gave 2-methyl-6-sulpho-4H-3, 1-benzoxazin-4-one which on reaction with ammonia gave the 2-methyl-4-oxo-3,4-dihydroquinazolin-6-sulfonic acid (1). This on further reaction with 4-nitro benzaldehyde and consequent reduction gave 2-[2-(4-aminophenyl) vinyl]-4-oxo-3, 4-dihydroquinazolone-6-sulfonic acid (3). Condensation with substituted aldehydes yields the title compounds 2-[2-{(4-substitutedbenzylidene)-phenyl}vinyl]-4-oxo-3,4-dihydroquin-azolone-6-sulfonic acid 4(a-l) which on further reaction with CAC (Chloro Acetyl Chloride) in presence of TEA (triethyl amine) in catalytic amount resulted into titled compound 2-[2-{4-(3-chloro-4-substituedphenyl-azetidin-2-one)-phenyl}vinyl]-4-oxo-3,4-dihydroquin-azolone -6-sulfonic acid 5(a-l). The compounds are confirmed by their elemental analysis (Table-I) , IR spectral analysis (Table-IIa) and 1 H NMR spectral analysis (Table-IIb) .
Experimental
All melting points were determined in PMP-DM scientific melting point apparatus and are uncorrected. The IR spectra were recorded in KBr on a "Perkin-Elmer RX 1 FT-IR" Spectrophotometer (serial No. 51448) and 1 H NMR spectra was recorded in CDCl 3 as well as mixture of CDCl 3 +DMSO with TMS as an internal Standard on 300 MHz "Bruker A/C 300 F Spectrophotometer".
Preparation of 2-methyl-4-oxo-3,4-dihydroquinazolin-6-sulfonic acid (1):
In a 250 mL Beaker 5-Sulpho anthranilic acid (2.17g, 0.01M) in presence of pyridine (0.79 g, 0.01M) were taken. Acetyl chloride (0.78 g, 0.01M) at 0º-5ºC was added drop wise to afford cyclization to give 2-methyl-6-sulpho-4H-3, 1-benzoxazin-4-one. The resulting compound on treatment with ammonia gave 2-methyl-4-oxo-3,4-dihydroquinazolin-6-sulfonic acid (1). The resulting solid was filetered, washed, dried and recrystallised from glacial acetic acid. The % yield was 85%, m.p 225ºC.
Preparation of 2-[2-(4-nitrophenyl) vinyl]-4-oxo-3,4-dihydroquinaz-oline-6-sulphonic acid (2):
In a 250 mL R.B.F a mixture of 2-methyl-4-oxo-3,4-dihydroquinazolin-6-sulfonic acid (1) (3.63g, 0.01M) and 4-Nitro benzaldehyde (1.51g, 0.01M) in acetic anhydride was taken. The reaction mixture was refluxed for 6-8 hrs and cooled to room temperature. The excess of solvent was then distilled off and then the contents were poured on to crushed ice. The resulting solid was filtered, washed, dried and recrystallised from glacial acetic acid. The % yield was 75%, m. p 210ºC.
Preparation of 2-[2-(4-aminophenyl) vinyl]-4-oxo-3,4-dihydroquinaz-oline-6-sulphonic acid (3):
In a 250 mL R.B.F 2-[2-(4-nitrophenyl) vinyl]-4-oxo-3,4-dihydroquinazoline-6-sulphonic acid (2) (7.46g, 0.02M) was taken. The solution of sodium sulphide (0.06M) in water (75mL) was added to it. The reaction mixture was refluxed for 2-3 hrs. A deep reddish brown solution was obtained. After cooling, it was diluted with water. The conc. HCl was added to the solution and was boiled gently till the removal of H 2 S was ceased completely. Neutralization with sodium carbonate precipitate 2-[2-(4-aminophenyl) vinyl]-4-oxo-3,4-dihydroquinazoline-6-sulphonic acid (3) as free amino compound as yellow product. The product was filtered, washed, dried and recrystallised from ethanol. The % yield is 60%, m.p 281ºC.
Preparation of 2-[2-{(4-substitutedbenzylidene)-phenyl} vinyl]-4-oxo-3, 4-dihydroquinazolone-6-sulfonic acid 4(a-l):-
In a 250 mL R.B.F 2-[2-(4-aminophenyl) vinyl]-4-oxo-3,4-dihydroquinazoline-6-sulphonic acid (3) (3.43g, 0.01M) and substituted benzaldehyde (0.01M) were taken in methanol (30 mL) as a solvent. The reaction mixture was refluxed with the help of reflux condenser attached with a dean-stark apparatus, till azeotropic removal of water. The reaction was carried out in presence of an acid catalyst. The resulting mixture was cooled and poured into crushed ice. The solid obtained was filtered, washed, dried and recrystallised by methanol. The % yield was 80%. IR: ν max 1630 (C=N), 1713 (C=O), 1410 (CH=CH), 1670 (>N=CH-); 1 H NMR (CDCl3+DMSO; TMS as internal standard): δ 7.1-8.1 (m, 3H, H-5, and H-7-8), δ 9.1 (broad, s, 1H, NH), δ 2.5 (d, 1H, CH=CH), δ 2.7 (d, 1H, CH=CH). 
Preparation of 2-[2-{(4-substitutedbenzylidene)-phenyl} vinyl]-4-oxo-3, 4-dihydroquinazolone-6-sulfonic acid 5(a-l)
In a 250 mL R.B. 
Result and Discussion

Antibacterial and antifungal activity
All the compounds (4a-4l & 5a-5l) from the series were screened for their antibacterial activity against B. subtillis, S. aureus, P. aeruginosa and E. coli. The standard drug used was ampicillin, amoxicillin and penicillin and DMF was kept as solvent control. Similarly the antifungal studies were carried out against fungus C. albicans and C. krusei, using Flucanozole as standard. Compounds 4e, 4h, 4i, 4j, 5a, 5f, 5h and 5k showed significant antibacterial activity. Compound 4d, 4e, 4f, 4l, 5a, 5e, 5f and 5l showed significant antifungal activity. The antibacterial and antifungal activity of compounds 4(a-l) and 5(a-l) are given in Table-III.  Table- 
Conclusion
All compounds were screened for their antifungal against Candida albicans and antibacterial against S.aureus, B.subtilis, E.coli and P.aeruginosa. Zone of inhibition were measured in millimeters. The antifungal activities of the test compounds were compared to the standard drug flucanozole (35-40mm). DMF was used as solvent. All compounds have shown good activity against candida albicans. Ampicillin (40-50mm), Amoxicillin (35-45mm) and penicillin (38-48mm) were used as standard drugs for antibacterial activity. Compounds 4e, 4h, 4i, 4j, 5a, 5f, 5h and 5k showed significant antibacterial activity. Compound 4d, 4e, 4f, 4l, 5a, 5e, 5f and 5l showed significant antifungal activity (Table-III) .
